Performance Evaluation​

The Korean Institute of Tuberculosis conducts performance testing and validation assessments to evaluate the feasibility of developing and commercializing in vitro diagnostic medical technologies or devices. We evaluate specificity, sensitivity, reproducibility, detection limit, precision, and other parameters of diagnostic reagents, kits, or assays for tuberculosis and non-tuberculous mycobacteria, and provide result reports based on these evaluations.​